Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
At its Annual Conference 2025, Edubex Learning highlighted its ambitious plans for 2026, including workforce doubling and new academic partnerships.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback